Your browser doesn't support javascript.
loading
Do we need more clinical trials in secondary progressive MS?
Lechner-Scott, J; Yeh, A; Levy, M; Hawkes, C; Giovannoni, G.
Afiliación
  • Lechner-Scott J; Dept of Neurology, John Hunter Hospital, University Newcastle, Australia.
  • Yeh A; Department of Pediatrics (Neurology), SickKids Research Institute, Division of Neurosciences and Mental Health, Hospital for Sick Children, University of Toronto, Toronto,Ontario, Canada.
  • Levy M; Department of Neurology, Massachusetts General Hospital and Harvard Medical School,Boston, MA, USA.
  • Hawkes C; Department of Neurology, Massachusetts General Hospital and Harvard Medical School,Boston, MA, USA.
  • Giovannoni G; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Mult Scler Relat Disord ; 60: 103790, 2022 04.
Article en En | MEDLINE | ID: mdl-35398712
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Crónica Progresiva / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2022 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Crónica Progresiva / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2022 Tipo del documento: Article País de afiliación: Australia